Delivery Order SPE2DB22D3004-SPE2DB24FPU70
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,454.89, is for the delivery of DESCOVY 200-25 MG TABLET medical product and has a completion date of May 15, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $17,764.29, is for the delivery of DESCOVY 200-25 MG TABLET pharmaceutical product. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is the prime contractor, and this delivery order is issued under a larger indefinite delivery contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of DESCOVY 200-25 MG TABLET (National Drug Code 4563601465) and has a potential value of $18,986.25. The period of performance runs from the award date of February 8, 2024 through February 9, 2024. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 MG TABLET. The contract has a ceiling value of $6,159.11 and an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing this medication as part of its role as a prime vendor under the DLA's Indefinite Delivery Contract (IDC) for medical commodities, valued at up to $999,999,999...
- This is a $18,193.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of DESCOVY 200-25 MG TABLET, a prescription medication. The contract has an ultimate completion date of May 30, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite...
- This is a $33,734.79 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S. The contract has an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle through December 2026....
- This is a $15,563.42 delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the supply of DESCOVY 200-25 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of August 20, 2024 and is a firm fixed price arrangement. Amerisourcebergen Drug Corp is a major supplier of pharmaceuticals and medical supplies to the federal government, supporting military treatment facilities, veterans' hospitals, and other...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,197.67, is for the supply of DESCOVY 200-25 MG TABLET, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of October 16, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DESCOVY 200-25 MG TABLET in 30-count units. The order has a potential value of $21,038.67 and a completion date of January 5, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and distribution services to support DLA Troop Support Medical operations. This delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $11,193.36 and a performance period through March 7, 2024. This award is part of a larger indefinite delivery contract...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPU70Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The order is for the supply of DESCOVY 200-25 MG TABLET (a pharmaceutical product) under a firm fixed price contract with a ceiling value of $8,010.56. The order has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This order appears to be part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 3/28/24 |